A. Angeles

Cytoplasmic redistribution and cleavage of AUF1 during coxsackievirus infection enhance the stability of its viral genome

X. Si, Honglin Luo, J. Wong, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Eligibility of real-world patients with chemo-refractory, K-RAS wild-type, metastatic colorectal cancer for palliative intent regorafenib monotherapy

W. Cheung, A. Angeles, Wayne Hung, 2018, Medical Oncology.

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

A. Zoubeidi, K. Chi, A. Azad, 2014, Oncotarget.

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.

M. Rubin, C. Collins, M. Gleave, 2017, Cancer discovery.

Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.

M. Nykter, M. Gleave, F. Saad, 2020, European urology.

BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression

A. Wyatt, M. Annala, K. Chi, 2021, Clinical Cancer Research.

Immune and non-immune functions of the immunoproteasome.

Honglin Luo, A. Angeles, G. Fung, 2012, Frontiers in bioscience.

Regulation of Osmotic Stress by OmpC but not OmpF Increases Kanamycin Resistance in Escherichia coli

Tina Chang, Lauren Coombe, A. Angeles, 2013 .

Immuno-Oncology Advances in Genitourinary Cancers.

S. Pal, A. Angeles, Peter D Zang, 2024, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.